CRIS Stock Analysis

CRIS -  USA Stock  

USD 7.63  0.09  1.19%

The latest fall in stock price could raise concerns from retail investors as the firm it trading at a share price of 7.63 on 3,633,639 in volume. The company directors and management have failed to build on market volatilities in May. However, diversifying your overall positions with Curis Inc may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 10.58. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Curis partners.
Continue to Trending Equities.

Search Stock Analysis 

The Curis stock analysis report makes it easy to digest most publicly released information about Curis and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. CRIS stock analysis module also helps to analyze the Curis price relationship with some important fundamental indicators such as market cap and management efficiency.

CRIS Stock Analysis Notes

About 87.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 0.62. Curis Inc had not issued any dividends in recent years. The entity had a split on the 30th of May 2018. Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Curis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people. For more info on Curis Inc please contact Ali Fattaey at 617 503-6500 or go to

Curis Quarterly Cost of Revenue


Curis Inc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Curis' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Curis Inc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Curis Inc generates negative expected return over the last 90 days
Curis Inc has high historical volatility and very poor performance
The company reported the previous year's revenue of 10.31 M. Net Loss for the year was (30.13 M) with loss before overhead, payroll, taxes, and interest of (12.77 M).
Curis Inc currently holds about 156.41 M in cash with (29.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71.
Curis Inc has a poor financial position based on the latest SEC disclosures
Over 87.0% of the company shares are held by institutions such as insurance companies
Latest headline from Law Firms Investigates Curis, Inc , Washington Prime Group Inc , Array Technologies Inc , And Ocugen For Misleading Shareholders - Tech Stock Observer

Curis Inc Upcoming and Recent Events

Earnings reports are used by Curis to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Curis previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of August 2021
Next Earnings Report9th of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

CRIS Largest EPS Surprises

Earnings surprises can significantly impact Curis' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Curis SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Curis prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Curis investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Curis Inc specific information freely available to individual and institutional investors to make a timely investment decision.
11th of June 2021
Financial Statements and Exhibits. Other Events
2nd of June 2021
Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Unclassified Corporate Event. Completion of Acquisition or Disposition of Assets
12th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
22nd of March 2021
Unclassified Corporate Event
16th of March 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
16th of February 2021
Unclassified Corporate Event
11th of February 2021
Unclassified Corporate Event
1st of February 2021
Unclassified Corporate Event

Curis Thematic Classifications

In addition to having Curis stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Cancer Fighters IdeaCancer Fighters
Public companies from health care and pharmaceutical sectors that are focused on fighting cancer

CRIS Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Curis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Curis Inc backward and forwards among themselves. Curis' institutional investor refers to the entity that pools money to purchase Curis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Ra Capital Management LpCommon Shares7.1 M80.8 M
Adage Capital Partners Gp LlcCommon Shares6.5 M73.6 M
Point72 Asset Management LpCommon Shares5.6 M63.6 M
State Street CorpCommon Shares4.5 M51.5 M
Sio Capital Management LlcCommon Shares4.4 M49.6 M
Orbimed Advisors LlcCommon Shares4.4 M49.4 M
Vanguard Group IncCommon Shares3.7 M41.9 M
Note, although Curis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

CRIS Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 690.05 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Curis's market, we take the total number of its shares issued and multiply it by Curis's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

CRIS Profitablity

Curis' profitability indicators refer to fundamental financial ratios that showcase Curis' ability to generate income relative to its revenue or operating costs. If, let's say, Curis is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Curis' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Curis' profitability requires more research than a typical breakdown of Curis' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (292.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (244.46) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -2.44.
Last ReportedProjected for 2021
Return on Investment(69.89) (75.41) 
Return on Average Assets(0.37) (0.40) 
Return on Average Equity(3.81) (3.91) 
Return on Invested Capital(1.42) (1.53) 
Return on Sales(2.76) (2.98) 

Management Efficiency

The entity has return on total asset (ROA) of (14.51) % which means that it has lost $14.51 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (73.8) %, meaning that it created substantial loss on money invested by shareholders. Curis management efficiency ratios could be used to measure how well curis inc manages its routine affairs as well as how well it operates its assets and liabilities. As of 06/20/2021, Return on Investment is likely to drop to -75.41. In addition to that, Return on Average Assets is likely to drop to -0.4. Curis Average Assets are relatively stable at the moment as compared to the past year. Curis reported last year Average Assets of 80.43 Million. As of 06/20/2021, Tangible Asset Value is likely to grow to about 210.8 M, while Return on Average Assets are likely to drop (0.40) .
Last ReportedProjected for 2021
Book Value per Share 2.69  2.90 
Enterprise Value over EBIT(16.00) (17.26) 
Enterprise Value over EBITDA(15.75) (17.00) 
Price to Book Value 3.69  3.94 
Tangible Assets Book Value per Share 4.01  3.25 
Enterprise Value466.1 M502.9 M
Tangible Asset Value195.4 M210.8 M

Technical Drivers

As of the 20th of June, Curis shows the risk adjusted performance of 0.0088, and Mean Deviation of 5.0. Curis Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for nineteen technical drivers for Curis Inc, which can be compared to its rivals. Please confirm Curis Inc standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Curis Inc is priced correctly, providing market reflects its regular price of 7.63 per share. Given that Curis has jensen alpha of 0.1653, we suggest you to validate Curis Inc's prevailing market performance to make sure the company can sustain itself at a future point.

Curis Inc Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Moving Average is predictive technique used to analyze Curis Inc price data points by creating a series of averages of different subsets of Curis entire price series. View also all equity analysis or get more info about all moving average overlap studies indicator.

Curis Inc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Curis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Curis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Curis insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Curis Technical and Predictive Indicators

Curis Forecast Models

Curis time-series forecasting models is one of many Curis' stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Curis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Curis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Curis stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CRIS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Curis. By using and applying CRIS Stock analysis, traders can create a robust methodology for identifying CRIS entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(72.18) (77.88) 
EBITDA Margin(2.73) (2.95) 
Gross Margin 0.95  0.91 
Profit Margin(2.76) (2.98) 
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment of non-hodgkin lymphomas, and acute myeloid leukemia and myelodysplastic syndromes and CI-8993, a monoclonal antibody designed to antagonize the V-domain Ig suppressor of T cell activation that is in Phase IaIb clinical trial in patients with solid tumors. The companys pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and PI3K enzymes for the treatment of patients with MYC-altered diffuse large B-cell lymphoma and solid tumors CA-170, an oral small molecule drug candidate for treating patients with advanced solid tumors and lymphomas and CA-327, a pre-investigational new drug stage oncology drug candidate. It has collaboration agreement with F. Hoffmann-La Roche Ltd. and Genentech Inc. for the development and commercialization of Erivedge, an orally-administered small molecule hedgehog signaling pathway inhibitor for the treatment of advanced basal cell carcinoma and with Aurigene Discovery Technologies Limited for the discovery, development, and commercialization of small molecule compounds in the areas of immuno-oncology and precision oncology. The company was incorporated in 2000 and is headquartered in Lexington, Massachusetts.

Current CRIS Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. CRIS analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. CRIS analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
17.75Strong Buy4Odds
Curis Inc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most CRIS analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand CRIS stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Curis Inc, talking to its executives and customers, or listening to CRIS conference calls.
CRIS Analyst Advice Details

CRIS Stock Analysis Indicators

Curis Inc stock analysis indicators help investors evaluate how Curis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Curis shares will generate the highest return on investment. By understating and applying Curis stock analysis, traders can identify Curis position entry and exit signals to maximize returns.
Quick Ratio22.69
Fifty Two Week Low0.90
Revenue Growth-19.20%
Shares Short Prior Month11.46M
Average Daily Volume Last 10 Day6.36M
Average Daily Volume In Three Month3.45M
Shares Percent Shares Out14.92%
Gross Margins-121.72%
Short Percent Of Float14.96%
Forward Price Earnings-15.71
Float Shares65.47M
Fifty Two Week High17.40
Enterprise Value To Ebitda-43.96
Fifty Day Average12.42
Two Hundred Day Average10.33
Enterprise Value To Revenue106.76
Continue to Trending Equities. Note that the Curis Inc information on this page should be used as a complementary analysis to other Curis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Complementary Tools for Curis Stock analysis

When running Curis Inc price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
The market value of Curis Inc is measured differently than its book value, which is the value of CRIS that is recorded on the company's balance sheet. Investors also form their own opinion of Curis' value that differs from its market value or its book value, called intrinsic value, which is Curis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curis' market value can be influenced by many factors that don't directly affect Curis Inc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curis' value and its price as these two are different measures arrived at by different means. Investors typically determine Curis value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.